These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

239 related articles for article (PubMed ID: 12110135)

  • 1. The contrasting roles of IL-2 and IL-15 in the life and death of lymphocytes: implications for the immunotherapy of rheumatological diseases.
    Waldmann T
    Arthritis Res; 2002; 4 Suppl 3(Suppl 3):S161-7. PubMed ID: 12110135
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The IL-2/IL-15 receptor systems: targets for immunotherapy.
    Waldmann TA
    J Clin Immunol; 2002 Mar; 22(2):51-6. PubMed ID: 11998892
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The shared and contrasting roles of IL2 and IL15 in the life and death of normal and neoplastic lymphocytes: implications for cancer therapy.
    Waldmann TA
    Cancer Immunol Res; 2015 Mar; 3(3):219-27. PubMed ID: 25736261
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Biology and immunotherapy advance of interleukin 2 and interleukin 15-review].
    Chen GH; Wu DP
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2009 Aug; 17(4):1088-92. PubMed ID: 19698267
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increasing the biological activity of IL-2 and IL-15 through complexing with anti-IL-2 mAbs and IL-15Rα-Fc chimera.
    Votavova P; Tomala J; Kovar M
    Immunol Lett; 2014; 159(1-2):1-10. PubMed ID: 24512738
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The biology of IL-15: implications for cancer therapy and the treatment of autoimmune disorders.
    Waldmann TA
    J Investig Dermatol Symp Proc; 2013 Dec; 16(1):S28-30. PubMed ID: 24326545
    [TBL] [Abstract][Full Text] [Related]  

  • 7. IL-15R alpha-IgG1-Fc enhances IL-2 and IL-15 anti-tumor action through NK and CD8+ T cells proliferation and activation.
    Wu Z; Xu Y
    J Mol Cell Biol; 2010 Aug; 2(4):217-22. PubMed ID: 20671116
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Contrasting roles of IL-2 and IL-15 in the life and death of lymphocytes: implications for immunotherapy.
    Waldmann TA; Dubois S; Tagaya Y
    Immunity; 2001 Feb; 14(2):105-10. PubMed ID: 11239443
    [No Abstract]   [Full Text] [Related]  

  • 9. Cutting Edge: Differential Fine-Tuning of IL-2- and IL-15-Dependent Functions by Targeting Their Common IL-2/15Rβ/γc Receptor.
    Meghnem D; Morisseau S; Frutoso M; Trillet K; Maillasson M; Barbieux I; Khaddage S; Leray I; Hildinger M; Quéméner A; Jacques Y; Mortier E
    J Immunol; 2017 Jun; 198(12):4563-4568. PubMed ID: 28507024
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The multifaceted regulation of interleukin-15 expression and the role of this cytokine in NK cell differentiation and host response to intracellular pathogens.
    Waldmann TA; Tagaya Y
    Annu Rev Immunol; 1999; 17():19-49. PubMed ID: 10358752
    [TBL] [Abstract][Full Text] [Related]  

  • 11. IL-2Ralpha-Directed monoclonal antibodies provide effective therapy in a murine model of adult T-cell leukemia by a mechanism other than blockade of IL-2/IL-2Ralpha interaction.
    Phillips KE; Herring B; Wilson LA; Rickford MS; Zhang M; Goldman CK; Tso JY; Waldmann TA
    Cancer Res; 2000 Dec; 60(24):6977-84. PubMed ID: 11156399
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cytokine-induced survival of activated T cells in vitro and in vivo.
    Vella AT; Dow S; Potter TA; Kappler J; Marrack P
    Proc Natl Acad Sci U S A; 1998 Mar; 95(7):3810-5. PubMed ID: 9520449
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Preclinical and phase I clinical trial of blockade of IL-15 using Mikbeta1 monoclonal antibody in T cell large granular lymphocyte leukemia.
    Morris JC; Janik JE; White JD; Fleisher TA; Brown M; Tsudo M; Goldman CK; Bryant B; Petrus M; Top L; Lee CC; Gao W; Waldmann TA
    Proc Natl Acad Sci U S A; 2006 Jan; 103(2):401-6. PubMed ID: 16387851
    [TBL] [Abstract][Full Text] [Related]  

  • 14. TransCon IL-2 β/γ: a novel long-acting prodrug with sustained release of an IL-2Rβ/γ-selective IL-2 variant with improved pharmacokinetics and potent activation of cytotoxic immune cells for the treatment of cancer.
    Rosen DB; Kvarnhammar AM; Laufer B; Knappe T; Karlsson JJ; Hong E; Lee YC; Thakar D; Zúñiga LA; Bang K; Sabharwal SS; Uppal K; Olling JD; Kjaergaard K; Kurpiers T; Schnabel M; Reich D; Glock P; Zettler J; Krusch M; Bernhard A; Heinig S; Konjik V; Wegge T; Hehn Y; Killian S; Viet L; Runz J; Faltinger F; Tabrizi M; Abel KL; Breinholt VM; Singel SM; Sprogøe K; Punnonen J
    J Immunother Cancer; 2022 Jul; 10(7):. PubMed ID: 35817480
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The multichain interleukin-2 receptor: a target for immunotherapy of patients receiving allografts.
    Waldmann TA; Goldman CK
    Am J Kidney Dis; 1989 Nov; 14(5 Suppl 2):45-53. PubMed ID: 2683757
    [TBL] [Abstract][Full Text] [Related]  

  • 16. T-cell receptors for cytokines: targets for immunotherapy of leukemia/lymphoma.
    Waldmann TA
    Ann Oncol; 2000; 11 Suppl 1():101-6. PubMed ID: 10707789
    [TBL] [Abstract][Full Text] [Related]  

  • 17. ALKS 4230: a novel engineered IL-2 fusion protein with an improved cellular selectivity profile for cancer immunotherapy.
    Lopes JE; Fisher JL; Flick HL; Wang C; Sun L; Ernstoff MS; Alvarez JC; Losey HC
    J Immunother Cancer; 2020 Apr; 8(1):. PubMed ID: 32317293
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cytokine-Mediated Regulation of CD8 T-Cell Responses During Acute and Chronic Viral Infection.
    Hashimoto M; Im SJ; Araki K; Ahmed R
    Cold Spring Harb Perspect Biol; 2019 Jan; 11(1):. PubMed ID: 29101105
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Selective Targeting of IL-15Rα Is Sufficient to Reduce Inflammation.
    Meghnem D; Maillasson M; Barbieux I; Morisseau S; Keita D; Jacques Y; Quéméner A; Mortier E
    Front Immunol; 2022; 13():886213. PubMed ID: 35592318
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prodigiosin blocks T cell activation by inhibiting interleukin-2Ralpha expression and delays progression of autoimmune diabetes and collagen-induced arthritis.
    Han SB; Park SH; Jeon YJ; Kim YK; Kim HM; Yang KH
    J Pharmacol Exp Ther; 2001 Nov; 299(2):415-25. PubMed ID: 11602650
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.